Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT04389697 Completed - Clinical trials for Cardiac Implantable Electronic Devices

Fasting Versus Non-Fasting for Cardiac Implantable Electronic Devices (FastCIED Study)

Start date: January 29, 2020
Phase: N/A
Study type: Interventional

There was no evidence to suggest that a shortened fluid fast results in an increased risk of aspiration, regurgitation or related morbidity compared with the standard 'nil by mouth from midnight' fasting policy. However, there is no available data regarding the safety and efficacy of fasting approach in patients undergoing cardiac implantable electronic device (CIED) procedures. The aim of this study is to demonstrate that a non-fasting protocol is non-inferior in regard to safety to a fasting protocol (current practice) in patients undergoing cardiac device implantation procedures

NCT ID: NCT04389671 Completed - COVID-19 Clinical Trials

The Safety and Preliminary Tolerability of Lyophilized Lucinactant in Adults With Coronavirus Disease 2019 (COVID-19)

Start date: January 5, 2021
Phase: Phase 2
Study type: Interventional

This is a multicenter, single-treatment study. Subjects will consist of adults with COVID-19 associated acute lung injury who are being cared for in a critical care environment.

NCT ID: NCT04389541 Completed - Clinical trials for Advanced Solid Tumors or Hematologic Malignancies

Clinical Research Platform on Decision Making and Clinical Impact of Biomarker-Driven Precision Oncology

INFINITY
Start date: April 17, 2020
Phase:
Study type: Observational [Patient Registry]

The retrospective cohort study INFINITY will be an instrument to analyze the current practice of precision oncology in the real-world setting. It will provide insight into real-world biomarker-directed treatment of cancer patients not eligible for standard therapies. The study will retrospectively collect medical records' data of patients who received a targeted treatment based on a potentially actionable alteration or biomarker identified by molecular diagnostics. Data of deceased patients will be included. The study will analyze how molecular test results guided clinical decision making. The compiled treatment and outcome data will be a valuable resource to analyze the use and effectiveness of targeted therapy approaches in biomarker-defined and entity-defined subpopulations of cancer patients. These signals might generate new insights and foster progress of targeted cancer treatment. The associated biomarker profiling module aims to set up a decentral biobank for future research on molecular alterations or central re-testing.

NCT ID: NCT04388826 Completed - Clinical trials for Respiratory Distress Syndrome, Adult

COVID-19 Treatment of Severe Acute Respiratory Syndrome With Veru-111

Start date: June 18, 2020
Phase: Phase 2
Study type: Interventional

To demonstrate the efficacy of VERU-111 in the treatment of SARS-Cov-2 Infection by assessing its effect on the proportion of subjects that are alive without respiratory failure at Day 22. Respiratory failure is defined as non-invasive ventilation or high-flow oxygen, intubation and mechanical ventilation, or ventilation with additional organ support (e.g., pressors, RRT, ECMO).

NCT ID: NCT04388813 Completed - COVID-19 Clinical Trials

Predictors of Severe COVID-19 Outcomes

PRESCO
Start date: May 28, 2020
Phase:
Study type: Observational

This is a longitudinal, multi-center, observational study collecting diverse biological measurements and clinical and epidemiological data for the purpose of enabling a greater understanding of the onset of severe outcomes, primarily acute respiratory distress syndrome (ARDS) and/or mortality, in patients presenting to the hospital with suspicion or diagnosis of COVID-19. We seek to understand whether there are early signatures that predict progression to ARDS, mortality, and/or other comorbid conditions. The duration of the study participation is approximately 3 months.

NCT ID: NCT04388072 Completed - Clinical trials for Neuromyelitis Optica Spectrum Disorders

An Diagnostic Cohort on AQP4-Immunoglobulin G Detection Kit

Start date: May 15, 2020
Phase:
Study type: Observational

The diagnostic cohort study could will be use to verify the clinical performance of the AQP4 -immunoglobulin G detection kit and whether it has a good correlation with the clinical diagnosis results. The applicability and accuracy of the kit in clinical diagnosis will be verified according to the measured data.

NCT ID: NCT04387994 Completed - Infertility, Female Clinical Trials

Determination of Circulating Placental Biomarkers Levels to Predict the Pregnancy Outcome of First Trimester After IVF.

Start date: June 12, 2020
Phase:
Study type: Observational

This study will assess the predictive potential of circulating placental biomarkers for spontaneous miscarriage within the following month in an IVF setting. It is hypothesized that a robust algorithm including one or more of these biomarkers may allow for the accurate same-day distinction between women with a low and high risk of a spontaneous miscarriage.

NCT ID: NCT04387474 Completed - Clinical trials for Hemiplegia Following Ischemic Stroke

The Effectiveness of Rehabilitation Training Based on Brain-computer Interface Technology to Improve the Upper Limb Motor Function of Ischemic Stroke.

REBUILT
Start date: May 10, 2020
Phase: N/A
Study type: Interventional

To evaluate the effectiveness and safety of rehabilitation training based on brain-computer interface in improving the upper motor function, self-care ability in daily life and quality of life in patients with ischemic stroke. This study adopts centralized uniform random 1:1 grouping, subjects will be randomly assigned to the experimental group and the control group. Randomization schemes are generated by statistical professionals using SAS software.

NCT ID: NCT04387253 Completed - Clinical trials for Identification of the Mother or Fetus Contamination by SARS Cov-2

Study of Late Fetal Loss in Poitou-Charentes. GYNE-COVID

Start date: May 23, 2020
Phase: N/A
Study type: Interventional

Maternal-fetal transmission in the second or third trimester of pregnancy of the SARS-COV-2 virus could explain some late fetal losses. Finding a cause in the context of fetal loss is essential for parents and caregivers. It helps to understand the history of the disease, to address the possible risk of a recurrence and to plan for future pregnancies. If the maternal-fetal transmission of COVID 19 is confirmed and that it is responsible for obstetric complications, a preventive action could be proposed to the patients by the preconception vaccination. The investigators are seeking to clarify the frequency of this transmission is information awaited by caregivers, women, couples in particular when the latter are in distress from late fetal loss.

NCT ID: NCT04387006 Completed - Clinical trials for Osteopathic Manipulative Treatment

Osteopathic Manipulative Treatment Induces Functional Connectivity Changes

Start date: September 30, 2017
Phase: N/A
Study type: Interventional

Osteopathic Manipulative Treatment (OMT) is a whole-body intervention mainly focused on correcting the somatic dysfunctions present in different regions of the body. Osteopathic research to date has mostly been concerned with various clinical conditions such as musculoskeletal disorders and primary headache. The neurophysiological effects underlying clinical improvements are still under debate. Although models explaining the therapeutic effects of OMT include the potential for higher brain mechanism, OMT effects on functional brain connectivity is not fully understood and still lacking in healthy adults. Magnetic resonance imaging (MRI) research includes several different approaches to estimate cortical functions. Several of these approaches have demonstrated functional brain changes associated with OMT. Using Arterial Spin Labeling MRI, recently was demonstrated that the treatment of somatic dysfunctions induces cerebral perfusion changes in asymptomatic young participant. Thus, the aim of this study is to explore the neural correlates associated with OMT effect in terms of cerebral functional connectivity, as derived by complex network analysis of resting state fMRI data recorded in asymptomatic young volunteers with somatic dysfunctions